相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
Guanglong Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors
Yongfang Yao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Synthesis, Crystal Structure and Anti-Leukemic Activity of 1,3-Dihydro-1-{1-[4-(4-phenylpyrrolo [1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one
Jean Guillon et al.
MOLBANK (2022)
Synthesis of novel 4,5-dihydropyrrolo[1,2-a]quinoxalines, pyrrolo[1,2-a]quinoxalin]-2-ones and their antituberculosis and anticancer activity
Vitthal B. Makane et al.
ARCHIV DER PHARMAZIE (2020)
1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity
Jean Guillon et al.
MOLBANK (2020)
New achievements in the synthesis of pyrrolo[1,2-a]quinoxalines
Alexey A. Kalinin et al.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2019)
Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold
Ting Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a] quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
Jean Guillon et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells
Vanessa Desplat et al.
CHEMMEDCHEM (2017)
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines
Vanessa Desplat et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, Synthesis and Antimalarial Activity of Some New Aminoalcohol-pyrrolo[1,2-a]quinoxaline Derivatives
Jean Guillon et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2016)
Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity
Fedora Grande et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III
Luisa Ronga et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Recent Progress in Biological Activities and Synthetic Methodologies of Pyrroloquinoxalines
Aiping Huang et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: Synthesis, and in vitro antimalarial activity - Part II
Jean Guillon et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II
Vanessa Desplat et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2010)
New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives:: Synthesis, and in vitro antimalarial activity
Jean Guillon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase
Vanessa Desplat et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents
Jean Guillon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions
Jean Guillon et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2007)
Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines
J Guillon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent
G Campiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
